Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing
PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionAuthor discusses the question, "Will outsourcing determination of antibiotic effectiveness allow drug companies to influence prescribing?"
CitationDoshi, P. (2016). Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing. BMJ, 352. DOI: 10.1136/bmj.h6849
KeywordNational Physicians Alliance FDA Task Force
21st Century Cures Act
Clinical and Laboratory Standards Institute
United States. Food and Drug Administration
Conflict of Interest
Microbial Sensitivity Tests--standards
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/6584
- The determinants of policy effectiveness.
- Authors: Potter CC, Harries J
- Issue date: 2006 Nov
- Keys to healthcare outsourcing success.
- Authors: Klein SR
- Issue date: 2006 Winter
- Regulating compounding pharmacies.
- Authors: Noble A
- Issue date: 2015 Jun
- Could State Regulations be the Next Frontier in Preemption Jurisprudence? Drug Compounding as a Case Study.
- Authors: Brown NA, Tomar E
- Issue date: 2016
- Eight more ways to deal with antibiotic resistance.
- Authors: Metz M, Shlaes DM
- Issue date: 2014 Aug